These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 35847556)

  • 1. Irradiation combined with PD-L1
    Zhao X; Hu S; Zeng L; Liu X; Song Y; Zhang Y; Chen Q; Bai Y; Zhang J; Zhang H; Pan Y; Shao C
    iScience; 2022 Aug; 25(8):104690. PubMed ID: 35847556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation Therapy Promotes Hepatocellular Carcinoma Immune Cloaking via PD-L1 Upregulation Induced by cGAS-STING Activation.
    Du SS; Chen GW; Yang P; Chen YX; Hu Y; Zhao QQ; Zhang Y; Liu R; Zheng DX; Zhou J; Fan J; Zeng ZC
    Int J Radiat Oncol Biol Phys; 2022 Apr; 112(5):1243-1255. PubMed ID: 34986380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adding liposomal doxorubicin enhances the abscopal effect induced by radiation/αPD1 therapy depending on tumor cell mitochondrial DNA and cGAS/STING.
    Wang L; Luo R; Onyshchenko K; Rao X; Wang M; Menz B; Gaedicke S; Grosu AL; Firat E; Niedermann G
    J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37640480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbon ion irradiation induces DNA damage in melanoma and optimizes the tumor microenvironment based on the cGAS-STING pathway.
    Guo Y; Shen R; Wang F; Wang Y; Xia P; Wu R; Liu X; Ye W; Tian Y; Wang D
    J Cancer Res Clin Oncol; 2023 Aug; 149(9):6315-6328. PubMed ID: 36745223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ATM inhibition augments type I interferon response and antitumor T-cell immunity when combined with radiation therapy in murine tumor models.
    Jin WJ; Zangl LM; Hyun M; Massoud E; Schroeder K; Alexandridis RA; Morris ZS
    J Immunother Cancer; 2023 Sep; 11(9):. PubMed ID: 37730275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of radiotherapy and PD-L1 blockade induces abscopal responses in EGFR-mutated lung cancer through activating CD8
    Xia WY; Shen YJ; Zhang CC; Qian LQ; Wang H; Wang K; Jin HZ; Zhu XR; Ding ZP; Zhang Q; Yu W; Feng W; Fu XL
    Transl Oncol; 2024 Oct; 48():102074. PubMed ID: 39106551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Riluzole Enhancing anti-PD-1 Efficacy by Activating cGAS/STING Signaling in Colorectal Cancer.
    Liang B; Khan M; Storts H; Zhang EH; Zheng X; Xing X; Claybon H; Wilson J; Li C; Jin N; Fishel R; Miles WO; Wang JJ
    Mol Cancer Ther; 2024 Oct; ():. PubMed ID: 39382075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Niraparib exhibits a synergistic anti-tumor effect with PD-L1 blockade by inducing an immune response in ovarian cancer.
    Meng J; Peng J; Feng J; Maurer J; Li X; Li Y; Yao S; Chu R; Pan X; Li J; Zhang T; Liu L; Zhang Q; Yuan Z; Bu H; Song K; Kong B
    J Transl Med; 2021 Oct; 19(1):415. PubMed ID: 34620163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ATR inhibitor AZD6738 enhances the antitumor activity of radiotherapy and immune checkpoint inhibitors by potentiating the tumor immune microenvironment in hepatocellular carcinoma.
    Sheng H; Huang Y; Xiao Y; Zhu Z; Shen M; Zhou P; Guo Z; Wang J; Wang H; Dai W; Zhang W; Sun J; Cao C
    J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32461345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FLASH X-ray spares intestinal crypts from pyroptosis initiated by cGAS-STING activation upon radioimmunotherapy.
    Shi X; Yang Y; Zhang W; Wang J; Xiao D; Ren H; Wang T; Gao F; Liu Z; Zhou K; Li P; Zhou Z; Zhang P; Shen X; Liu Y; Zhao J; Wang Z; Liu F; Shao C; Wu D; Zhang H
    Proc Natl Acad Sci U S A; 2022 Oct; 119(43):e2208506119. PubMed ID: 36256824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PD-L1 deficiency sensitizes tumor cells to DNA-PK inhibition and enhances cGAS-STING activation.
    Xue Z; Zheng S; Linghu D; Liu B; Yang Y; Chen MK; Huang H; Song J; Li H; Wang J; Hung MC; Zhong D; Sun L
    Am J Cancer Res; 2022; 12(5):2363-2375. PubMed ID: 35693073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anlotinib suppresses proliferation, migration, and immune escape of gastric cancer cells by activating the cGAS-STING/IFN-β pathway.
    Yuan M; Guo XL; Chen JH; He Y; Liu ZQ; Zhang HP; Ren J; Xu Q
    Neoplasma; 2022 Jul; 69(4):807-819. PubMed ID: 35471977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosomes Shuttle TREX1-Sensitive IFN-Stimulatory dsDNA from Irradiated Cancer Cells to DCs.
    Diamond JM; Vanpouille-Box C; Spada S; Rudqvist NP; Chapman JR; Ueberheide BM; Pilones KA; Sarfraz Y; Formenti SC; Demaria S
    Cancer Immunol Res; 2018 Aug; 6(8):910-920. PubMed ID: 29907693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Hybrid Nanoadjuvant Simultaneously Depresses PD-L1/TGF-β1 and Activates cGAS-STING Pathway to Overcome Radio-Immunotherapy Resistance.
    Yi L; Jiang X; Zhou Z; Xiong W; Xue F; Liu Y; Xu H; Fan B; Li Y; Shen J
    Adv Mater; 2024 Apr; 36(15):e2304328. PubMed ID: 38229577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IFN-γ activates the tumor cell-intrinsic STING pathway through the induction of DNA damage and cytosolic dsDNA formation.
    Xiong H; Xi Y; Yuan Z; Wang B; Hu S; Fang C; Cai Y; Fu X; Li L
    Oncoimmunology; 2022; 11(1):2044103. PubMed ID: 35273829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineered sTRAIL-armed MSCs overcome STING deficiency to enhance the therapeutic efficacy of radiotherapy for immune checkpoint blockade.
    Huang KC; Chiang SF; Chang HY; Chen WT; Yang PC; Chen TW; Liang JA; Shiau AC; Ke TW; Clifford Chao KS
    Cell Death Dis; 2022 Jul; 13(7):610. PubMed ID: 35835756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anlotinib enhances the antitumor immunity of radiotherapy by activating cGAS/STING in non-small cell lung cancer.
    Han D; Zhang J; Bao Y; Liu L; Wang P; Qian D
    Cell Death Discov; 2022 Nov; 8(1):468. PubMed ID: 36443299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. α-PD-L1 mAb enhances the abscopal effect of hypo-fractionated radiation by attenuating PD-L1 expression and inducing CD8
    Wang H; Lin X; Luo Y; Sun S; Tian X; Sun Y; Zhang S; Chen J; Zhang J; Liu X; Liu H; Gong Y; Xie C
    Immunotherapy; 2019 Feb; 11(2):101-118. PubMed ID: 30511887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Programmed Death Ligand 1 Indicates Pre-Existing Adaptive Immune Response by Tumor-Infiltrating CD8
    Li YM; Yu JM; Liu ZY; Yang HJ; Tang J; Chen ZN
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31627272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymerase θ inhibition activates the cGAS-STING pathway and cooperates with immune checkpoint blockade in models of BRCA-deficient cancer.
    Patterson-Fortin J; Jadhav H; Pantelidou C; Phan T; Grochala C; Mehta AK; Guerriero JL; Wulf GM; Wolpin BM; Stanger BZ; Aguirre AJ; Cleary JM; D'Andrea AD; Shapiro GI
    Nat Commun; 2023 Mar; 14(1):1390. PubMed ID: 36914658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.